SUMMARY OF THE INVENTIONIn accordance with the objective, the present invention provides a lyophilized parental formulation consisting of antibacterial agent daptomycin as active, tocopheryl phosphate hydrolysate mixture (TPM), which acts as an antioxidant as well as solubilizer. The present composition increases the stability of the product at room temperature after reconstitution, improves the reconstitution time, thus accelerating the administration process to the patient in need of.
Patent History
Publication number: 20150216928
Type: Application
Filed: Aug 22, 2013
Publication Date: Aug 6, 2015
Applicant: AGILA SPECIAL TIES PRIVATE LIMITED (BANGALORE, KA)
Inventors: Satya Srinivas Chetlapalli (Bangalore), Srirama Sarveswara Rao Mandavilli (Bangalore), Babu Justin (Bangalore), Sathyanarayan Srinivas Meda (Bangalore)
Application Number: 14/431,170
- Forums
- ASX - By Stock
- POH
- Ann: Phosphagenics Receives Further Arbitration Process Update
Ann: Phosphagenics Receives Further Arbitration Process Update, page-118
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add POH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.0¢ |
Change
0.000(0.00%) |
Mkt cap ! n/a |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
POH (ASX) Chart |
Day chart unavailable